Table of Contents
<< Previous Issue | Jul 2004 (Vol: 2004, Issue: 49) | Next Issue >> |
- Section: Company Profile
-
Sereno SA
- Section: Distribution & Marketing
-
Abbott Acquires Remaining Rights to Trandolapril from Aventis
- Section: Licensing
-
CuraGen Licenses TopoTarget’s HDAC Inhibitor
- Section: Mergers & Acquisitions
-
UCB Tenders US$2.7 B Offer to Acquire Celltech
- Section: Research & Development
-
Yamanouchi and Pfizer Streamline Partnership for Japan
-
MorphoSys and Novartis Sign Antibody Agreement